Agios Pharmaceuticals Inc AGIO

NAS: AGIO | ISIN: US00847X1046 17/10/2025

42,33 USD (+1,95%)

(+1,95%) 17/10/2025

Grafiek Agios Pharmaceuticals Inc

Grafiek Agios Pharmaceuticals Inc

1 dag1d 1,95%
1 week1w 3,45%
1 maand1m 10,84%
3 maanden3m 6,04%
6 maanden6m 54,83%
1 jaar1j -7,29%
5 jaar5j 19,24%

donderdag 30 oktober 2025, 11:30

Kwartaalcijfers (3de kwartaal)

Agios Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

12 april 2023 · Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero · Persbericht

18 maart 2021 · Agios Sponsors Program Promoting Health Literacy for Patients with Sickle Cell Disease · Persbericht

26 februari 2021 · Agios Recognizes 14th Annual Rare Disease Day and Raises Awareness of Unmet Needs in Rare Hemolytic Anemias · Persbericht

25 februari 2021 · Agios Reports Fourth Quarter and Full Year 2020 Financial Results · Persbericht

23 februari 2021 · Agios to Present at March Investor Conferences · Persbericht

26 januari 2021 · Agios Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused · Persbericht

17 januari 2021 · Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma · Persbericht

11 januari 2021 · Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation · Persbericht

5 januari 2021 · Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 · Persbericht

Profiel Agios Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.agios.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe